Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Dominant disease-causing effect of NOD2 mutations in a family with all family members affected by Crohn's disease.
Schnitzler F, Seiderer J, Stallhofer J, Brand S. Schnitzler F, et al. Inflamm Bowel Dis. 2012 Feb;18(2):395-6. doi: 10.1002/ibd.21882. Epub 2011 Oct 12. Inflamm Bowel Dis. 2012. PMID: 21994160 No abstract available.
Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy.
Schnitzler F, Fidder H, Ferrante M, Ballet V, Noman M, Van Assche G, Spitz B, Hoffman I, Van Steen K, Vermeire S, Rutgeerts P. Schnitzler F, et al. Inflamm Bowel Dis. 2011 Sep;17(9):1846-54. doi: 10.1002/ibd.21583. Epub 2011 Jan 6. Inflamm Bowel Dis. 2011. PMID: 21830263
Predictors of early response to infliximab in patients with ulcerative colitis.
Ferrante M, Vermeire S, Katsanos KH, Noman M, Van Assche G, Schnitzler F, Arijs I, De Hertogh G, Hoffman I, Geboes JK, Rutgeerts P. Ferrante M, et al. Among authors: schnitzler f. Inflamm Bowel Dis. 2007 Feb;13(2):123-8. doi: 10.1002/ibd.20054. Inflamm Bowel Dis. 2007. PMID: 17206703 Clinical Trial.
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease.
Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, Hoffman I, Van Steen K, Vermeire S, Rutgeerts P. Schnitzler F, et al. Inflamm Bowel Dis. 2009 Sep;15(9):1295-301. doi: 10.1002/ibd.20927. Inflamm Bowel Dis. 2009. PMID: 19340881
Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype Status.
Stallhofer J, Friedrich M, Konrad-Zerna A, Wetzke M, Lohse P, Glas J, Tillack-Schreiber C, Schnitzler F, Beigel F, Brand S. Stallhofer J, et al. Among authors: schnitzler f. Inflamm Bowel Dis. 2015 Oct;21(10):2327-40. doi: 10.1097/MIB.0000000000000515. Inflamm Bowel Dis. 2015. PMID: 26263469
Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease.
Dambacher J, Staudinger T, Seiderer J, Sisic Z, Schnitzler F, Pfennig S, Hofbauer K, Konrad A, Tillack C, Otte JM, Diebold J, Göke B, Ochsenkühn T, Lohse P, Brand S. Dambacher J, et al. Among authors: schnitzler f. Inflamm Bowel Dis. 2007 Jan;13(1):71-82. doi: 10.1002/ibd.20008. Inflamm Bowel Dis. 2007. PMID: 17206642
Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective study.
Seiderer J, Brand S, Herrmann KA, Schnitzler F, Hatz R, Crispin A, Pfennig S, Schoenberg SO, Göke B, Lohse P, Ochsenkuhn T. Seiderer J, et al. Among authors: schnitzler f. Inflamm Bowel Dis. 2006 Dec;12(12):1114-21. doi: 10.1097/01.mib.0000235836.32176.5e. Inflamm Bowel Dis. 2006. PMID: 17119385
Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes.
Glas J, Török HP, Tonenchi L, Müller-Myhsok B, Mussack T, Wetzke M, Klein W, Epplen JT, Griga T, Schiemann U, Lohse P, Seiderer J, Schnitzler F, Brand S, Ochsenkühn T, Folwaczny M, Folwaczny C. Glas J, et al. Among authors: schnitzler f. Inflamm Bowel Dis. 2006 Jul;12(7):606-11. doi: 10.1097/01.ibd.0000225346.23765.6b. Inflamm Bowel Dis. 2006. PMID: 16804398
The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, Dambacher J, Seiderer J, Tillack C, Konrad A, Crispin A, Göke B, Lohse P, Ochsenkühn T. Brand S, et al. Among authors: schnitzler f. Inflamm Bowel Dis. 2005 Jul;11(7):645-52. doi: 10.1097/01.mib.0000168372.94907.d2. Inflamm Bowel Dis. 2005. PMID: 15973118
Formation of antinuclear and double-strand DNA antibodies and frequency of lupus-like syndrome in anti-TNF-α antibody-treated patients with inflammatory bowel disease.
Beigel F, Schnitzler F, Paul Laubender R, Pfennig S, Weidinger M, Göke B, Seiderer J, Ochsenkühn T, Brand S. Beigel F, et al. Among authors: schnitzler f. Inflamm Bowel Dis. 2011 Jan;17(1):91-8. doi: 10.1002/ibd.21362. Inflamm Bowel Dis. 2011. PMID: 20564536
36 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback